PRTK - Paratek Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
All numbers in thousands
Revenue31/12/201831/12/201731/12/201631/12/2015
Total revenue17,11712,61629-
Cost of revenue-60,07283,46050,765
Gross profit17,117-47,456-83,431-50,765
Operating expenses
Research development57,50857,50857,50857,508
Selling general and administrative63,65836,96526,40019,988
Non-recurring----
Others----
Total operating expenses121,16697,037109,86070,753
Operating income or loss-104,049-84,421-109,831-70,753
Income from continuing operations
Total other income/expenses net-7,805-3,895-1,805-107
Earnings before interest and taxes-104,049-84,421-109,831-70,753
Interest expense-10,985-5,079-3,223-770
Income before tax-111,854-88,316-111,636-70,860
Income tax expense502753--
Minority interest----
Net income from continuing ops-112,356-89,069-111,636-70,860
Non-recurring events
Discontinued operations----
Extraordinary items----
Effect of accounting changes----
Other items----
Net income
Net income-112,356-89,069-111,636-70,860
Preferred stock and other adjustments----
Net income applicable to common shares-112,356-89,069-111,636-70,860